In the original version of this article the author name Gerardo Di Scala was originally presented incorrectly as ‘Di Scala Gerardo’; this has been corrected in this article.

Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4) / Vitale A.; Emmi G.; Lopalco G.; Fabiani C.; Gentileschi S.; Silvestri E.; Di Scala G.; Iannone F.; Frediani B.; Galeazzi M.; Lapadula G.; Rigante D.; Cantarini L.. - In: CLINICAL RHEUMATOLOGY. - ISSN 0770-3198. - ELETTRONICO. - 38:(2019), pp. 267-267. [10.1007/s10067-018-4302-0]

Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4)

Emmi G.;Silvestri E.;Di Scala G.;
2019

Abstract

In the original version of this article the author name Gerardo Di Scala was originally presented incorrectly as ‘Di Scala Gerardo’; this has been corrected in this article.
2019
38
267
267
Goal 3: Good health and well-being for people
Vitale A.; Emmi G.; Lopalco G.; Fabiani C.; Gentileschi S.; Silvestri E.; Di Scala G.; Iannone F.; Frediani B.; Galeazzi M.; Lapadula G.; Rigante D.; Cantarini L.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1197697
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact